Step aside, psilocybin: A new shroom is in town. According to a new study by researchers at the University of California (UC) San Diego’s Herbert Wertheim School of Public Health and Human Longevity Science, the use of Amanita muscaria mushrooms has surged in the U.S. based upon Google searches. The research indicates Google searches increased… Keep Reading
Recently, researchers Christopher P. Holstege and Rita Farah unveiled the results of their study on the increase in poison center calls for mushroom consumption. In “Psilocybin Exposures Reported to U.S. Poison Centers: National Trends Over a Decade,” the researchers explored the rising trend of accidental exposure to psilocybin between January 1, 2024-December 31, 2022. Holstege… Keep Reading
A new study examined the effects of psilocybin in an animal model for treating anorexia nervosa, showing that the compound improves body weight maintenance in female rats, facilitating what they call cognitive flexibility. Anorexia nervosa (AN) is deadly—having one of the highest mortality rates of any known psychiatric disease. It killed people such as Karen… Keep Reading
The results of a recent study found that closer proximity to cannabis dispensaries in a community leads to a lower rate of opioid prescription. The study entitled “Recreational cannabis dispensary access effects on prescription opioid use and mortality,” was made available online in June but will be published in Regional Science and Urban Economics in… Keep Reading
University of California, Berkeley (UC Berkeley) will observe human subjects in a study to determine if psilocybin, the active compound in magic mushrooms.The study marks UC Berkeley’s first study involving human subjects with a Schedule I substance—drugs with no currently accepted medical value. The study will examine how psilocybin changes the way our brain interprets… Keep Reading
Get paid to smoke weed? A deal made in heaven and a study could help investigators better understand how cannabis cultivation and processing impacts the final product—in quantifiable terms. Today the team behind pre-roll and rolling paper maker DaySavers announced their partnership with the Cannabis Research Coalition and The Network of Applied Pharmacognosy (NAP) to… Keep Reading
A 41-year-old woman in a case study reported remarkable improvements of longhauler’s symptoms after taking psilocybin and MDMA-assisted therapy sessions. A case report, “Long-COVID symptoms improved after MDMA and psilocybin therapy: A case report,” was published May 24 in the journal Clinical Case Reports. The woman in the case study was healthy before contracting COVID-19… Keep Reading
A recent study published in Biocatalysis and Agricultural Biotechnology analyzed the possibilities of genetically engineering cannabis to ensure consistency and targeting specifical cannabinoids. In “Using Advanced Biotechnological Techniques to Improve Cannabis Cultivars,” researchers from the University of Lethbridge’s Department of Biological Sciences in Alberta, Canada, explored the benefits of gene editing in cannabis. “Inherent breeding… Keep Reading
A new study based on data collected by law enforcement agencies suggests the availability of illicit psilocybin mushrooms in the U.S. has risen significantly compared to prior years. This uptick in psilocybin seizures suggests that the mushrooms are now easier to find on the street. Researchers at New York University (NYU) uncovered a rapidly growing… Keep Reading
Cannabis does not cause “next-day impairment” researchers found in a new study published last week in the journal Psychopharmacology. Researchers found little evidence to suggest that THC can impact a person’s performance the next day, though any experienced smoker could tell you the same. Researchers observed 20 adults with physician-diagnosed insomnia who consumed cannabis irregularly,… Keep Reading
